Investment Rating - The investment rating for the company is "Buy" with a market price of HKD 16.24 and a sector rating of "Outperform" [2]. Core Views - The company has shown steady revenue growth with a slight decline in net profit. The gross margin has rebounded, and cash on hand has increased by double digits. The company maintains a strong strategic focus on core cities in first and second-tier areas, which lays a solid foundation for future high-quality development. Despite the ongoing industry sales slump, the company has demonstrated resilience in both sales and land acquisition, leading to a maintained "Buy" rating [5]. Summary by Sections Financial Performance - In 2024, the company achieved operating revenue of RMB 1429.9 billion, a year-on-year increase of 6.4%. The net profit attributable to shareholders was RMB 48.0 billion, a decrease of 4.6%. The proposed cash dividend is HKD 1.2 per share, with a payout ratio of 47% [4][5]. - The gross margin for 2024 was 13.3%, an increase of 2.2 percentage points year-on-year. The net profit margin and attributable net profit margin were 4.5% and 3.4%, respectively, both showing slight declines [8][11]. Revenue and Profit Forecast - The company has adjusted its revenue forecasts for 2025-2026 due to the current industry conditions. Expected revenues for 2025, 2026, and 2027 are RMB 1478 billion, RMB 1383 billion, and RMB 1351 billion, with year-on-year growth rates of 3%, -6%, and -2%, respectively. The net profit for the same years is projected to be RMB 50 billion, RMB 50 billion, and RMB 51 billion, with growth rates of 3%, 1%, and 2% [5][7]. Cash and Debt Management - As of the end of 2024, the company held cash of RMB 572.6 billion, a year-on-year increase of 12%. The interest-bearing debt was RMB 845.0 billion, up 5.7%. The net debt ratio stood at 26.6%, and the cash-to-short-term debt ratio was 9.35X, indicating a strong liquidity position [8][18][21]. Sales and Market Position - The company ranked seventh in the industry for sales in 2024, with a sales amount of RMB 1335 billion, a decline of 29.4% year-on-year. The sales area was 611 million square meters, also down 29.3%. The sales price per square meter was RMB 20,500, a decrease of 1.1% [23][31][25]. - The sales return rate reached 102%, an increase of 4 percentage points from the previous year, indicating effective cash collection [8]. Land Acquisition - The company acquired land worth RMB 530 billion in 2024, a decrease of 40% year-on-year, ranking sixth in the industry for land acquisition. The land acquisition intensity was 40%, which, despite a decline, remains relatively high [38][44].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [3]. Core Insights - The company reported a total order amount of 3.506 billion yuan in 2024, a year-on-year increase of 49.3%. Revenue reached 2.306 billion yuan, up 17.3% year-on-year, with a net profit attributable to shareholders of 272 million yuan, reflecting a 42.8% increase [1]. - The company has expanded its workforce, with 1,703 securities personnel and 342 investment advisors, marking increases of 1.5% and 18.3% respectively. The number of live broadcasts surged to 26,500, totaling over 49,800 hours, a growth of 110% [2]. - The product matrix has been optimized, leading to a significant increase in paying users. The number of paying users for large products and small products reached 181,500, with a notable decrease in the overall refund rate to 21.8% [2]. - The introduction of AI tools has enhanced operational efficiency, with a reduction in employee numbers by 11.1% while still supporting revenue growth. The company's cost expenses increased by 14.0%, but the expense ratios for sales, management, and R&D decreased [2]. Financial Forecasts - Revenue projections for 2025-2027 are estimated at 3.441 billion, 4.064 billion, and 4.673 billion yuan, with year-on-year growth rates of 49.21%, 18.10%, and 15.00% respectively. Net profit forecasts for the same period are 927 million, 1.206 billion, and 1.440 billion yuan, with growth rates of 240.42%, 30.05%, and 19.43% respectively [3][6]. - The report indicates a projected P/E ratio of 19.44, 14.95, and 12.52 for the years 2025, 2026, and 2027 respectively [3].

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is a leader in the recombinant collagen sector, showing strong growth in revenue and profit, with a projected revenue of 5.54 billion yuan in 2024, representing a year-on-year increase of 57.1% [8] - The company's online and offline sales channels are experiencing significant growth, with direct-to-consumer (DTC) online sales increasing by 66.5% and offline direct sales doubling [8] - The core product lines, particularly the "Kefumei" brand, are performing exceptionally well, with a 62.9% increase in revenue [8] - The company's profitability remains robust, with a gross margin of 82.1% and a net profit margin of 37.2% [8] Financial Summary - Total revenue is projected to grow from 3.53 billion yuan in 2023 to 5.54 billion yuan in 2024, with a compound annual growth rate (CAGR) of 57.07% [1][9] - Net profit is expected to rise from 1.45 billion yuan in 2023 to 2.06 billion yuan in 2024, reflecting a year-on-year growth of 42.06% [1][9] - Earnings per share (EPS) is forecasted to increase from 1.40 yuan in 2023 to 1.99 yuan in 2024 [1][9] - The price-to-earnings (P/E) ratio is projected to decrease from 44.64 in 2023 to 31.42 in 2024, indicating a more attractive valuation over time [1][9]

——美丽田园医疗健康（2373.HK）2024 年年报点评 买入（维持） 当前价：18.10 港元 作者 分析师：姜浩 执业证书编号：S0930522010001 021-52523680 jianghao@ebscn.com 联系人：吴子倩 2025 年 3 月 28 日 公司研究 深化"内生+外延"双轮驱动，"双美+双保健"业务模式焕发光彩 wuziqian@ebscn.com 市场数据 | 总股本(亿股) | 2.36 | | --- | --- | | 总市值(亿港元)： | 42.68 | | 一年最低/最高(港元)： | 13.03/19.88 | | 近 3 月换手率： | 11.66% | 股价相对走势 | 收益表现 | | | | | --- | --- | --- | --- | | % | 1M | 3M | 1Y | | 相对 | 4.60 | -12.75 | 24.88 | | 绝对 | 2.77 | 7.61 | 25.30- | | 资料来源：Wind | | | - | 相关研报 中国双美模式龙头企业，稳扎稳打开拓美与 健康大市场——美丽田园医疗健康 （2373.HK）首次覆 ...

减值大幅收窄致归母净利大涨，非经营性及客观因素致核心归母 净利下降。24 年商誉及其他无形资产减值+金融资产及合同资产减 值损失合共 16.5 亿元，同比减少 24.2 亿元，使得经营利润同比 +144.4%。非经营性因素（少确认风险客商收入影响约 15%、长账 龄应收等坏账计提损失影响约 45%）及客观因素（非业主增值 、城服、商业运营、其他服务的经营利润下降，影响约 60%）共同 导致核心归母净利下降 22.9%。 业绩 2025 年 3 月 27 日，公司发布 2024 全年业绩：实现收入 439.93 亿元，同比+3.2%；归母净利润 18.08 亿元，同比+518.7%；核心 归母净利润 30.38 亿元，同比-22.9%。 经营分析 核心业务保持增长，占比进一步提升。24 年核心业务（物管服务+ 社区增值+三供一业）收入同比+9.4%，加回风险客商未收款后的 收入同比+10.2%。核心业务占总收入比例达 87%，同比+4.9pct。 压降关联方风险，独立性逐步加强。24 年关联方应收款原值压降 4.5 亿至 25.5 亿，计提减值拨备比例 74%。加回风险客商未收款 前，持续关连交易实际发生额占总 ...

Investment Rating - The investment rating for the company is "Outperform the Market" and is maintained [2][17]. Core Insights - The company achieved a comprehensive revenue of 170.43 billion RMB in 2024, representing a year-on-year increase of 15.4%, with core net profit growing by 20.1% to 35.07 billion RMB [7][8]. - The comprehensive gross margin and net profit margin attributable to the parent company were 32.91% and 21.30%, respectively, both showing improvements compared to the previous year [7][8]. - The board declared a final dividend of 0.643 RMB per share, an increase of 33.7% year-on-year, maintaining a total payout ratio of 100% for 2024 [7][8]. Financial Performance Summary - **Revenue and Profit Forecasts**: - Revenue is projected to grow from 14,767 million RMB in 2023 to 19,797 million RMB in 2025, with a compound annual growth rate (CAGR) of 16.2% [6]. - Net profit is expected to increase from 2,929 million RMB in 2023 to 4,300 million RMB in 2025, reflecting a CAGR of 18.5% [6]. - The fully diluted EPS is forecasted to rise from 1.28 RMB in 2023 to 1.88 RMB in 2025 [6]. - **Margins and Returns**: - The gross margin is expected to improve from 31.8% in 2023 to 32.91% in 2025, while the return on equity (ROE) is projected to increase from 18.4% to 21.96% over the same period [6][16]. Business Segment Performance - **Commercial Segment**: - The commercial segment achieved retail sales of 215 billion RMB in 2024, a year-on-year increase of 18.7%, outperforming the retail sales growth of the broader market [11][12]. - The company opened 21 new shopping centers in 2024, bringing the total to 122 operational centers, with 50 centers leading in local market sales [11][12]. - **Property Management Segment**: - The total managed area reached 413 million square meters, a year-on-year increase of 11.6%, with a focus on expanding in first and second-tier cities [13]. - The company signed 3,485 million square meters of new third-party contracts, enhancing its market position [13]. - **Membership Business**: - The membership program saw a 32.0% increase in total members, reaching 61.07 million, with significant growth in cross-industry point redemption [17]

公司研究 深化"内生+外延"双轮驱动，"双美+双保健"业务模式焕发光彩 ——美丽田园医疗健康（2373.HK）2024 年年报点评 2025 年 3 月 28 日 买入（维持） 当前价：18.10 港元 作者 | 总股本(亿股) | 2.36 | | --- | --- | | 总市值(亿港元)： | 42.68 | | 一年最低/最高(港元)： | 13.03/19.88 | | 近 3 月换手率： | 11.66% | 股价相对走势 | 收益表现 | | | | | --- | --- | --- | --- | | % | 1M | 3M | 1Y | | 相对 | 4.60 | -12.75 | 24.88 | | 绝对 | 2.77 | 7.61 | 25.30- | | 资料来源：Wind | | | - | 相关研报 中国双美模式龙头企业，稳扎稳打开拓美与 健康大市场——美丽田园医疗健康 （2373.HK）首次覆盖报告（2023-06-02） 分析师：姜浩 执业证书编号：S0930522010001 021-52523680 jianghao@ebscn.com 联系人：吴子倩 wuziqian ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is a leader in the recombinant collagen sector, showing strong performance with a revenue of 5.54 billion yuan in 2024, representing a year-on-year growth of 57.1% [8] - The adjusted net profit for 2024 is projected at 2.06 billion yuan, with a year-on-year increase of 42.1% [8] - The company has a strong online and offline sales growth, with direct-to-consumer (DTC) online sales increasing by 66.5% and offline direct sales doubling [8] - The company maintains a high gross margin of 82.1% despite a slight decline due to product type expansion [8] - Future profit forecasts have been adjusted upwards, with net profit estimates for 2025 and 2026 increased to 2.57 billion yuan and 3.21 billion yuan, respectively [8] Financial Summary - Total revenue is projected to grow from 3.53 billion yuan in 2023 to 11.62 billion yuan by 2027, with a compound annual growth rate (CAGR) of approximately 28.23% [1] - The net profit is expected to rise from 1.45 billion yuan in 2023 to 4.05 billion yuan in 2027, reflecting a CAGR of about 25.88% [1] - The earnings per share (EPS) is forecasted to increase from 1.40 yuan in 2023 to 3.91 yuan in 2027 [1] - The price-to-earnings (P/E) ratio is projected to decrease from 44.64 in 2023 to 16.01 by 2027, indicating improving valuation [1]

Investment Rating - The report maintains a "Buy" rating for China Resources Vientiane Life (01209.HK) [1] Core Views - The company achieved a total revenue of 17.04 billion yuan in 2024, representing a year-on-year growth of 15.4%, with core net profit reaching 3.51 billion yuan, up 20.1% year-on-year [8] - The company’s overall gross margin improved to 32.9%, an increase of 1.1 percentage points year-on-year, while the sales and management expense ratio decreased by 0.9 percentage points to 7.4% [8] - The company opened 21 new shopping centers in 2024, maintaining its leading position in the industry with 122 managed projects [8] - The company reported a healthy cash flow with a 100% dividend payout ratio, distributing a total dividend of 1.536 yuan per share [8] - The report projects a decrease in net profit for 2025-2026 due to market conditions, with expected net profits of 4.35 billion yuan and 5.09 billion yuan respectively [8] Financial Summary - Total revenue forecast for 2024 is 17.04 billion yuan, with a growth rate of 15.41% [9] - The projected net profit for 2024 is 3.63 billion yuan, reflecting a growth rate of 23.92% [9] - The earnings per share (EPS) for 2024 is estimated at 1.59 yuan, with a price-to-earnings (P/E) ratio of 20.02 [9] - The company’s total assets are projected to reach 28.91 billion yuan in 2024, with a debt-to-asset ratio of 42.16% [9]

Investment Rating - The report maintains a "Buy" rating for China Resources Vientiane Life (01209.HK) [1] Core Views - The company achieved a total revenue of 17.04 billion yuan in 2024, representing a year-on-year growth of 15.4%, with core net profit increasing by 20.1% to 3.51 billion yuan [8] - The company’s overall gross margin improved to 32.9%, up by 1.1 percentage points year-on-year, while the sales and management expense ratio decreased by 0.9 percentage points to 7.4% [8] - The company opened 21 new shopping centers in 2024, maintaining its leading position in the industry with 122 managed projects [8] - The company reported a retail sales growth of 18.7% in managed shopping centers, reaching 215 billion yuan, and rental income increased by 19.2% to 26.2 billion yuan [8] - The company has a healthy cash flow with a 100% dividend payout ratio, distributing a total dividend of 1.536 yuan per share [8] Financial Summary - Total revenue forecast for 2024 is 17.04 billion yuan, with a projected growth rate of 15.4% [9] - The net profit for 2024 is expected to be 3.63 billion yuan, reflecting a growth of 23.9% [9] - The earnings per share (EPS) for 2024 is projected at 1.59 yuan, with a price-to-earnings (P/E) ratio of 20.02 [9] - The company’s total assets are estimated to reach 28.91 billion yuan in 2024, with a debt-to-asset ratio of 42.16% [9]